Literature DB >> 29351514

The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Robson Augusto Souza Santos1, Walkyria Oliveira Sampaio1, Andreia C Alzamora1, Daisy Motta-Santos1, Natalia Alenina1, Michael Bader1, Maria Jose Campagnole-Santos1.   

Abstract

The renin-angiotensin system (RAS) is a key player in the control of the cardiovascular system and hydroelectrolyte balance, with an influence on organs and functions throughout the body. The classical view of this system saw it as a sequence of many enzymatic steps that culminate in the production of a single biologically active metabolite, the octapeptide angiotensin (ANG) II, by the angiotensin converting enzyme (ACE). The past two decades have revealed new functions for some of the intermediate products, beyond their roles as substrates along the classical route. They may be processed in alternative ways by enzymes such as the ACE homolog ACE2. One effect is to establish a second axis through ACE2/ANG-(1-7)/MAS, whose end point is the metabolite ANG-(1-7). ACE2 and other enzymes can form ANG-(1-7) directly or indirectly from either the decapeptide ANG I or from ANG II. In many cases, this second axis appears to counteract or modulate the effects of the classical axis. ANG-(1-7) itself acts on the receptor MAS to influence a range of mechanisms in the heart, kidney, brain, and other tissues. This review highlights the current knowledge about the roles of ANG-(1-7) in physiology and disease, with particular emphasis on the brain.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29351514      PMCID: PMC7203574          DOI: 10.1152/physrev.00023.2016

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  638 in total

1.  Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet.

Authors:  Sérgio Henrique S Santos; Luciana Rodrigues Fernandes; Camila Santos Pereira; André L Senna Guimarães; Alfredo M B de Paula; Maria José Campagnole-Santos; Jacqueline Isaura Alvarez-Leite; Michael Bader; Robson Augusto S Santos
Journal:  Regul Pept       Date:  2012-06-29

2.  Differential baroreceptor reflex modulation by centrally infused angiotensin peptides.

Authors:  M J Campagnole-Santos; S B Heringer; E N Batista; M C Khosla; R A Santos
Journal:  Am J Physiol       Date:  1992-07

3.  Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla.

Authors:  Patrícia Maria Ferreira; Robson Augusto Souza Dos Santos; Maria José Campagnole-Santos
Journal:  Regul Pept       Date:  2007-01-20

Review 4.  Central and peripheral actions of angiotensin-(1-7).

Authors:  R A Santos; M J Campagnole-Santos
Journal:  Braz J Med Biol Res       Date:  1994-04       Impact factor: 2.590

5.  Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.

Authors:  Kulwinder Singh; Tajinder Singh; P L Sharma
Journal:  Ther Adv Cardiovasc Dis       Date:  2011-05-09

Review 6.  Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

Authors:  Kathleen Rodgers; Shelagh Verco; Laura Bolton; Gere Dizerega
Journal:  Expert Opin Investig Drugs       Date:  2011-10-06       Impact factor: 6.206

7.  Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.

Authors:  Yingchuan Li; Zhen Zeng; Yachun Li; Weifeng Huang; Ming Zhou; Xiaoli Zhang; Wei Jiang
Journal:  Shock       Date:  2015-04       Impact factor: 3.454

8.  Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.

Authors:  Walkyria O Sampaio; Carlos Henrique de Castro; Robson A S Santos; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Hypertension       Date:  2007-11-05       Impact factor: 10.190

9.  Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.

Authors:  Wang Wang; Vaibhav B Patel; Nirmal Parajuli; Dong Fan; Ratnadeep Basu; Zuocheng Wang; Tharmarajan Ramprasath; Zamaneh Kassiri; Josef M Penninger; Gavin Y Oudit
Journal:  J Mol Med (Berl)       Date:  2014-04-15       Impact factor: 4.599

10.  Angiotensin-(1-7)/Mas Signaling Inhibits Lipopolysaccharide-Induced ADAM17 Shedding Activity and Apoptosis in Alveolar Epithelial Cells.

Authors:  Xinhua Ma; Daomiao Xu; Yuhang Ai; Shuangping Zhao; Lina Zhang; Guangfeng Ming; Zhiyong Liu
Journal:  Pharmacology       Date:  2015-12-08       Impact factor: 2.547

View more
  261 in total

1.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

Review 2.  Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.

Authors:  Andrew M South; Hossam A Shaltout; Lisa K Washburn; Alexa S Hendricks; Debra I Diz; Mark C Chappell
Journal:  Clin Sci (Lond)       Date:  2019-01-08       Impact factor: 6.124

Review 3.  Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways.

Authors:  Shuzhen Guo; Angel T Som; Ken Arai; Eng H Lo
Journal:  Brain Res       Date:  2019-07-26       Impact factor: 3.252

4.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

Review 5.  Commonalities Between COVID-19 and Radiation Injury.

Authors:  Carmen I Rios; David R Cassatt; Brynn A Hollingsworth; Merriline M Satyamitra; Yeabsera S Tadesse; Lanyn P Taliaferro; Thomas A Winters; Andrea L DiCarlo
Journal:  Radiat Res       Date:  2021-01-01       Impact factor: 2.841

6.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 7.  Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19.

Authors:  Ziyin Huang; Yufeng Jiang; Jingjing Chen; Yafeng Zhou
Journal:  Cardiol J       Date:  2020-04-14       Impact factor: 2.737

8.  Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?

Authors:  Concepción Peiró; Salvador Moncada
Journal:  Circulation       Date:  2020-04-03       Impact factor: 29.690

9.  Sex differences in the central and peripheral manifestations of ischemia-induced heart failure in rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-05       Impact factor: 4.733

Review 10.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.